The majority of studies proposed in Projects 1-5 of this Conte center application will focus on the cell-type specific analysis of neuronal cell populations implicated in the pathophysiology of schizophrenia and their response to treatment with antipsychotic drugs. These studies will examine cellular processes ranging from mRNA transcription and translation, chromatin modification, protein phosphorylation, dendritic morphology, to whole cellular physiology and animal behavior. Virtually all of these investigations will make use of genetically modified mice, and thus the Animal Core will be devoted to facilitating these experiments. The existence of a centralized facility staffed with experienced personnel will ensure that all the mice needed for the proposed studies are available when needed, in a cost-effective manner.
Aim 1 of the Core will be the production of new Bacterial Artificial Chromosome (BAC) transgenic mouse lines.
In Aim 2, the testing of these transgenic animals will be characterized so as to validate them for use in the proposed studies. Finally, Aim 3 of the Core will be the breeding and maintenance of these and other existing mouse lines that will be used throughout the studies carried out in Projects 1-5.
to public health: Schizophrenia is a debilitating psychiatric disorder affecting ~1 % of the population. New therapeutic treatments for schizophrenia are needed. The Animal Core will provide the care and breeding of the animal models necessary for work of this Conte Center Grant.
|Seo, J-S; Zhong, P; Liu, A et al. (2018) Elevation of p11 in lateral habenula mediates depression-like behavior. Mol Psychiatry 23:1113-1119|
|Xu, Jian; Kurup, Pradeep; Nairn, Angus C et al. (2018) Synaptic NMDA Receptor Activation Induces Ubiquitination and Degradation of STEP61. Mol Neurobiol 55:3096-3111|
|Nectow, Alexander R; Moya, Maria V; Ekstrand, Mats I et al. (2017) Rapid Molecular Profiling of Defined Cell Types Using Viral TRAP. Cell Rep 19:655-667|
|Milosevic, Ana; Liebmann, Thomas; Knudsen, Margarete et al. (2017) Cell- and region-specific expression of depression-related protein p11 (S100a10) in the brain. J Comp Neurol 525:955-975|
|Sebel, Luke E; Graves, Steven M; Chan, C Savio et al. (2017) Haloperidol Selectively Remodels Striatal Indirect Pathway Circuits. Neuropsychopharmacology 42:963-973|
|Ceglia, Ilaria; Lee, Ko-Woon; Cahill, Michael E et al. (2017) WAVE1 in neurons expressing the D1 dopamine receptor regulates cellular and behavioral actions of cocaine. Proc Natl Acad Sci U S A 114:1395-1400|
|Seo, J-S; Wei, J; Qin, L et al. (2017) Cellular and molecular basis for stress-induced depression. Mol Psychiatry 22:1440-1447|
|Nishi, Akinori; Matamales, Miriam; Musante, Veronica et al. (2017) Glutamate Counteracts Dopamine/PKA Signaling via Dephosphorylation of DARPP-32 Ser-97 and Alteration of Its Cytonuclear Distribution. J Biol Chem 292:1462-1476|
|Xu, Jian; Kurup, Pradeep; Azkona, Garikoitz et al. (2016) Down-regulation of BDNF in cell and animal models increases striatal-enriched protein tyrosine phosphatase 61 (STEP61 ) levels. J Neurochem 136:285-94|
|Rapanelli, Maximiliano; Frick, Luciana R; Horn, Kyla D et al. (2016) The Histamine H3 Receptor Differentially Modulates Mitogen-activated Protein Kinase (MAPK) and Akt Signaling in Striatonigral and Striatopallidal Neurons. J Biol Chem 291:21042-21052|
Showing the most recent 10 out of 45 publications